Who is investing in synthetic biology?
How the three main public players in the emerging business of synthetic biology measure up.
| Company / Ticker | Recent Price | Notable Investors |
|---|---|---|
| Soaring Eagle Acquisition / SRNG* | 9.93 | Ark Investment, Baillie Gifford, Cascade Investment (Bill Gates) |
| Zymergen / ZY | 34.99 | SoftBank Vision fund, Baillie Gifford |
Is there a synthetic biology ETF?
SPDR S&P Biotech ETF (XBI) First Trust NYSE Arca Biotechnology ETF (FBT) VanEck Biotech ETF (BBH) iShares Genomics Immunology and Healthcare ETF (IDNA)
What are synthetic biology companies?
Top Public Companies
- #5. Codexis. Revenue: $69.056 million in 2020; $18.032 million in Q1 2021.
- #4. Ginkgo Bioworks. Revenue: $77 million in 2020.
- #3. Twist Bioscience.
- #2. Precigen.
- #1. Amyris.
- #5. Apeel Sciences.
- #3. ElevateBio.
- #2. National Resilience (Resilience)
Is synthetic biology in demand?
According to this research report from IndustryARC, the global synthetic biology market size was between $12.80 billion to $13.86 billion in 2018, and the market demand is projected to grow at a phenomenal CAGR of 36% to 38% during the forecast period of 2019 to 2025.
Did Cathie buy Zymergen?
You’d think Wood would have exited the company entirely. On the contrary, Wood made her biggest purchase in Zymergen yet on Aug. 4, buying 2.47 million shares, helping the stock recoup all of its losses from the previous day, and then some.
What’s a SPAC stock?
A SPAC is a special purpose acquisition company — basically, a pile of cash reserved for a merger that went through the initial public offering (IPO) process. The entire point of the SPAC is to find a private company to merge with.
Which ETF holds Crispr?
The ARK Innovation ETF (ARKK) and ARK Genomic Revolution ETF (ARKG) cumulatively bought up hundreds of thousands of shares of Crispr (ticker: CRSP) in the week leading up to its release of trial data on its gene-edited cancer drug, CTX110.
Is synthetic biology the future?
The Future Of Synthetic Biology and The Companies Using These Technologies. The market of synthetic biology is estimated to worth 11 billion by 2028. The increasing demands by biotechnological and pharmaceutical companies have greatly contributed to the growth of its market.
What is synthetic biology examples?
Some examples of what scientists are producing with synthetic biology are: Microorganisms harnessed for bioremediation to clean pollutants from our water, soil and air.
Why is synthetic biology bad?
The misuse of synthetic biology can be leveraged for strategic effect, such as economic damage due to industrial sabotage. Rather than the traditional paradigm of considering biological weapons as weapons of mass destruction, DiEuliis highlighted that synthetic biology may be leveraged as a weapon of mass disruption.
What happened to Zymergen?
However, Zymergen dropped a bomb in August when it ruled out any potential revenue in 2021 and 2022, citing technical issues with Hyaline among other things, and announced the abrupt exit of its then-CEO, Josh Hoffman.
Who are the leading companies in synthetic biology?
In brief, Twist is a leading name in the synthetic biology industry today. The company’s core work revolves around its proprietary DNA synthesis platform. Twist’s platform essentially works to industrialize the engineering of biology.
Which is the best description of synthetic biology?
Synthetic biology is a field of science that involves redesigning organisms for useful purposes by engineering them to have new abilities. Synthetic biology researchers and companies around the world are harnessing the power of nature to solve problems in medicine, manufacturing and agriculture.
Why is Bill Gates investing in synthetic biology?
Microsoft (MSFT) founder Bill Gates, who was an early investor in Beyond Meat, is pouring money into synthetic biology. He helped fund Ginkgo Bioworks, which is developing custom-built microbes, as well as Pivot Bio, a sustainable agriculture company.
How is the federal government regulating synthetic biology?
More broadly, the federal government has a policy in place, called the Coordinated Framework for Regulation of Biotechnology, to oversee the introduction of synthetic biology products into the market. For additional resources about the ethics, governance and societal implications of synthetic biology]